Association between plasma venetoclax trough levels and serum C-reactive protein levels in patients with acute myeloid leukemia treated with venetoclax plus azacitidine.

Yasu, Takeo; Gando, Yoshito; Shirota, Mikio; Kosugi, Nobuharu; Kobayashi, Masayuki

Yasu, Takeo; Gando, Yoshito; Shirota, Mikio; Kosugi, Nobuharu; Kobayashi, Masayuki.

Afiliação

Yasu T; Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Tokyo, Japan.
Gando Y; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo, Japan.
Shirota M; Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Kosugi N; Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Tokyo, Japan.
Kobayashi M; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo, Japan.

Leuk Lymphoma ; 65(1): 128-131, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37797220

Assuntos

Proteína C-Reativa; Leucemia Mieloide Aguda; Sulfonamidas; Humanos; Azacitidina/uso terapêutico; Compostos Bicíclicos Heterocíclicos com Pontes/efeitos adversos; Leucemia Mieloide Aguda/diagnóstico; Leucemia Mieloide Aguda/tratamento farmacológico; Leucemia Mieloide Aguda/induzido quimicamente; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Proteína C-Reativa / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google